Horizon Therapeutics Public Ltd Co

JPMORGAN CHASE & CO

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

5,042,293

Value ($000)

583,343

Weight

0.1%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	583,343	0.1%	5,042,293	9/30/2023
2023 Q2	8/11/2023	564,774	0.1%	5,491,240	6/30/2023
2023 Q1	5/18/2023	598,829	0.1%	5,486,771	3/31/2023
2022 Q4	2/13/2023	1,280,123	0.2%	11,248,889	12/31/2022
2022 Q3	11/14/2022	420,088	0.1%	6,787,642	9/30/2022
2022 Q2	8/11/2022	530,605	0.1%	6,652,529	6/30/2022
2022 Q1	5/11/2022	643,725	0.1%	6,118,479	3/31/2022
2021 Q4	2/11/2022	655,282	0.1%	6,080,954	12/31/2021
2021 Q3	11/12/2021	636,889	0.1%	5,814,230	9/30/2021
2021 Q2	8/12/2021	562,901	0.1%	6,011,329	6/30/2021
2021 Q1	5/12/2021	518,662	0.1%	5,635,181	3/31/2021
2020 Q4	2/19/2021	432,166	0.1%	5,907,934	12/31/2020
2020 Q3	11/12/2020	403,353	0.1%	5,160,610	9/30/2020
2020 Q2	8/11/2020	261,216	0.1%	4,699,798	6/30/2020
2020 Q1	5/12/2020	122,451	0.0%	4,134,098	3/31/2020
2019 Q4	2/11/2020	135,548	0.0%	3,744,444	12/31/2019